Najmul Islam Siddiqi

Najmul Siddiqi practices at Cardiovascular Care Inc in Los Alamitos, California.

Najmul Siddiqi's NPI, 1407003916, was assigned on August 26, 2008. Najmul Siddiqi holds Ohio license 57.014452.

Najmul Siddiqi's primary practice is Cardiovascular Care Inc, at 3801 Katella Ave, Los Alamitos, CA 90720 in Orange County. The practice phone is (562) 598-3200.

Najmul Siddiqi's primary practice is Cardiovascular Care Inc in Los Alamitos, California. Najmul Siddiqi is also affiliated with UCI Health - Orange. The medical group on file is Cardiovascular Care Associates. Dmand AI also links Najmul Siddiqi to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Najmul Siddiqi practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Najmul Siddiqi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Najmul Siddiqi is licensed in Ohio.

CMS data shows 997 Medicare services from Najmul Siddiqi across 16 procedure codes in 2024, for 581 Medicare patients. Medicare paid $52,340 for them.

CMS counts 581 Medicare patients who saw Najmul Siddiqi in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Najmul Siddiqi's median patient age at 71, with 46% women.

In 2024, Najmul Siddiqi wrote 1,356 Medicare Part D claims for 319 patients. 89% of them were for generic drugs. CMS names the drug for 1,201 of them, across 19 drugs with 11 or more claims each, at $87,594 in total drug cost. In 2023, CMS named 1,550 claims across 22 drugs.

Najmul Siddiqi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 141 general payments to Najmul Siddiqi from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $382.